X-ray diffraction study on the structural properties of poly-l-lactic acid (PLLA), polylactic acid (PLA), and polycaprolactone (PCL)
|
Full Text |
Pdf
|
|
Author |
Muhammad Afrizal, Rifky Ismail, Deni Fajar Fitriyana, Athanasius Priharyoto Bayuseno, Parlaungan Siregar and Chandra Liza
|
|
e-ISSN |
1819-6608 |
|
On Pages
|
1044-1052
|
|
Volume No. |
20
|
|
Issue No. |
14
|
|
Issue Date |
October 31, 2025
|
|
DOI |
https://doi.org/10.59018/0725121
|
|
Keywords |
PLA, PLLA, PCL, biomaterial, biopolymer, X-ray diffraction, biomedical applications.
|
Abstract
The growing need for biodegradable polymers in medical applications has underlined the significance of knowing their structural properties, notably those of Poly-L-Lactic Acid (PLLA), Polylactic Acid (PLA), and Polycaprolactone (PCL). These polymers exhibit significant potential for biomaterial development, attributed to their biodegradability, biocompatibility, and mechanical properties. This study analyzes the crystallographic properties of PLLA, PLA, and PCL through X-ray diffraction (XRD) to enhance understanding of their structural characteristics and performance in medical applications. The main aim is to analyze these polymers' structural differences, as these elements significantly affect their mechanical properties, flexibility, and biodegradation rates. The methods utilized involve the preparation of powder pellets from each polymer, followed by XRD analysis conducted with a Shimadzu XRD-7000 instrument, where diffraction data were collected over a 2θ range of 20° to 80°. The results demonstrate unique XRD patterns for each polymer, with PLLA showing pronounced peaks at 10.05°, 22.64°, and 39.43°, signifying high crystallinity, which is associated with enhanced mechanical strength and reduced degradation rates. PLA exhibited multiple peaks at 19.76°, 22.74°, and 28.82°, indicating a well-organized crystalline structure, whereas PCL displayed a characteristic peak at 22.42°, signifying its semi-crystalline nature. The study concludes that XRD is essential for elucidating the crystallographic characteristics of these polymers, facilitating the optimization of material properties for biomedical applications, including tissue engineering, drug delivery systems, and biodegradable implants. The findings contribute to the advancement of safer and more efficient biomaterials for clinical applications.
Back